Audio

Community Oncology Podcast - Pazopanib in soft tissue sarcoma

Publish date: November 30, 2012

 

Dr. David Henry's podcast covers highlights of the November issue including pazopanib in soft tissue sarcoma and dasatinib in first-line treatment of chronic myeloid leukemia.

Recommended Reading

Laparoscopy Tops Open Resection for Most Gastric Tumors
MDedge Hematology and Oncology
Regorafenib Delays Progression of Refractory Metastatic GIST
MDedge Hematology and Oncology
FDA Announces Limited Leucovorin Recall
MDedge Hematology and Oncology
FDA Warns of QT Prolongation with Ondansetron Dose
MDedge Hematology and Oncology
Washington Post Blasts Proliferation of ESAs for Anemia
MDedge Hematology and Oncology
Kaposi's Sarcoma Makes Unwelcome Return
MDedge Hematology and Oncology
Doxorubicin Remains First-Line Standard for Metastatic Soft-Tissue Sarcomas
MDedge Hematology and Oncology
Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Frontline Metastatic Soft Tissue Sarcoma (PICASSO III)
MDedge Hematology and Oncology
A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced L-Sarcoma
MDedge Hematology and Oncology
Efficacy and Safety of Masitinib (AB1010) in Comparison to Imatinib in Patients With Gastrointestinal Stromal Tumor
MDedge Hematology and Oncology